We are live on ! Find out more
EP

Eversept Partners Portfolio holdings

AUM $1.93B
1-Year Est. Return 160.8%
This Fund
S&P 500
This Quarter Est. Return
+3.54%
1 Year Est. Return
+160.8%
3 Year Est. Return
+321.09%
5 Year Est. Return
+420.29%
10 Year Est. Return
–
AUM
$1.45B
AUM Growth
-$54.5M
Cap. Flow
+$154M
Cap. Flow %
10.62%
Top 10 Hldgs %
43.38%
Holding
129
New
42
Increased
32
Reduced
24
Closed
24

Top Buys

Rank Stock Value
1
LH icon
Labcorp
LH
+$37.6M
2
CYH icon
Community Health Systems
CYH
+$28.3M
3
ASND icon
Ascendis Pharma A/S
ASND
+$27.8M
4
CTLT
CATALENT, INC.
CTLT
+$23M
5
MASI
Masimo
MASI
+$18.2M

Top Sells

Rank Stock Value
1
QGEN icon
Qiagen
QGEN
+$26.7M
2
AMRN
Amarin Corp
AMRN
+$24.9M
3
OGN icon
Organon & Co
OGN
+$21.2M
4
DHR icon
Danaher
DHR
+$17.4M
5
AMN icon
AMN Healthcare
AMN
+$15.8M

Sector Composition

Rank Sector Weight
1 Healthcare 80.74%
2 Miscellaneous 17.65%
3 Industrials 1.16%
4 Financials 0.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AZN icon
26
CALL
AstraZeneca
AZN
$252B
$15.6M 1.08%
+130,150
New +$15.2M
FATE icon
27
Fate Therapeutics
FATE
$291M
$15.5M 1.07%
260,895
-85,452
-25% -$6.7M
GSK icon
28
GSK
GSK
$102B
$15.4M 1.07%
321,323
+231,180
+256% +$11.6M
IONS icon
29
Ionis Pharmaceuticals
IONS
$10.1B
$15.1M 1.05%
450,501
+8,501
+2% +$320K
CYH icon
30
CALL
Community Health Systems
CYH
$413M
$12.6M 0.87%
+1,077,200
New +$14.1M
GH icon
31
Guardant Health
GH
$21.7B
$12.5M 0.87%
100,361
+98,552
+5,448% +$11.7M
NTRA icon
32
Natera
NTRA
$47B
$12.5M 0.86%
112,189
+102,875
+1,105% +$11.8M
SNY icon
33
Sanofi
SNY
$107B
$12.5M 0.86%
+259,128
New +$13.2M
ELV icon
34
Elevance Health
ELV
$85.5B
$11.8M 0.82%
31,628
+21,496
+212% +$8.17M
ZGNX
35
DELISTED
Zogenix, Inc.
ZGNX
$11.8M 0.81%
774,591
+278,731
+56% +$4.35M
TARO
36
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$11.4M 0.79%
179,366
+5,117
+3% +$354K
ALNY icon
37
Alnylam Pharmaceuticals
ALNY
$31.7B
$11.2M 0.77%
59,233
+8,097
+16% +$1.52M
EXEL icon
38
Exelixis
EXEL
$13.5B
$10.9M 0.75%
516,307
+336,307
+187% +$6.25M
MGLN
39
DELISTED
Magellan Health Services, Inc.
MGLN
$9.9M 0.68%
104,700
– –
HUM icon
40
Humana
HUM
$46.3B
$9.39M 0.65%
24,083
+5,427
+29% +$2.3M
TEVA icon
41
CALL
Teva Pharmaceuticals
TEVA
$42.5B
$9.37M 0.65%
962,400
+769,500
+399% +$7.21M
HCA icon
42
HCA Healthcare
HCA
$90.5B
$9.31M 0.64%
38,366
+30,052
+361% +$7.35M
CNC icon
43
Centene
CNC
$32B
$8.79M 0.61%
141,107
+73,107
+108% +$4.88M
ITCI
44
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$8.6M 0.6%
230,744
+113,282
+96% +$3.94M
RVTY icon
45
Revvity
RVTY
$14.4B
$8.16M 0.56%
+47,081
New +$8.3M
NSTG
46
DELISTED
NanoString Technologies, Inc.
NSTG
$8.1M 0.56%
+168,668
New +$9.7M
HZNP
47
CALL
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$7.67M 0.53%
70,000
– –
HQY icon
48
HealthEquity
HQY
$7.97B
$7.41M 0.51%
114,378
-83,122
-42% -$5.77M
QGEN icon
49
Qiagen
QGEN
$8.9B
$7.4M 0.51%
134,960
-479,002
-78% -$26.7M
IRTC icon
50
iRhythm Holdings
IRTC
$3.96B
$6.67M 0.46%
+113,854
New +$6.03M
1
2
3 4 5

Similar funds

SWM
Segment Wealth Management Houston, Texas $1.93B AUM 29.24% 1-Year Est. Return
RIA
Regal Investment Advisors Kentwood, Michigan $1.92B AUM 23.13% 1-Year Est. Return
SI
Standard Investments New York $1.93B AUM 6.23% 1-Year Est. Return
SG
Sourcerock Group Denver, Colorado $1.92B AUM 45.54% 1-Year Est. Return
DCP
Distillate Capital Partners Chicago, Illinois $1.92B AUM 5.31% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
GIA
Guyasuta Investment Advisors Pittsburgh, Pennsylvania $1.94B AUM 32.92% 1-Year Est. Return
MFM
MHR Fund Management New York $1.92B AUM 119.57% 1-Year Est. Return

Eversept Partners's Q3 2021 Portfolio in Review

As of Q3 2021, Eversept Partners held 129 positions worth $1.45B, down 3.6% from $1.5B the previous quarter. Its ten largest holdings account for 43% of the portfolio.

Eversept Partners deployed $154M of net new capital in Q3 2021, opening 42 new positions and adding to 32 existing holdings. Its largest new stake was Labcorp: 149,354 shares worth $36.1M.

By sector, the portfolio is most concentrated in Healthcare at 81% of assets, up from 65% a quarter earlier, followed by Miscellaneous and Industrials.

On the sell side, the largest reduction was Qiagen, an estimated $26.7M trimmed.

  • Eversept Partners's largest Q3 2021 buy was Labcorp: 149,354 shares worth $36.1M.
  • Eversept Partners added most to Community Health Systems in Q3 2021, an estimated $28.3M increase.
  • Eversept Partners's biggest Q3 2021 reduction was Qiagen, cutting an estimated $26.7M.
  • Eversept Partners fully exited Organon & Co in Q3 2021, selling an estimated $21.2M.
  • Eversept Partners's ten largest holdings make up 43% of its $1.45B portfolio in Q3 2021.
  • Eversept Partners opened 42 new positions and closed 24 in Q3 2021.
  • Eversept Partners's portfolio value fell 3.6% quarter-over-quarter to $1.45B.

Based on Eversept Partners's 13F filing for Q3 2021, filed 15 Nov 2021.